תוצאות חיפוש - Bogenrieder, Thomas

Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma מאת Bogenrieder, Thomas, Herlyn, Meenhard

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies מאת Simpson, Aaron, Petnga, Wilfride, Macaulay, Valentine M., Weyer-Czernilofsky, Ulrike, Bogenrieder, Thomas

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer מאת Ireland, Lucy, Santos, Almudena, Campbell, Fiona, Figueiredo, Carlos, Hammond, Dean, Ellies, Lesley G., Weyer-Czernilofsky, Ulrike, Bogenrieder, Thomas, Schmid, Michael, Mielgo, Ainhoa

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

CHK1 inhibition exacerbates replication stress induced by IGF blockade מאת Wu, Xiaoning, Seraia, Elena, Hatch, Stephanie B., Wan, Xiao, Ebner, Daniel V., Aroldi, Francesca, Jiang, Yanyan, Ryan, Anderson J., Bogenrieder, Thomas, Weyer-Czernilofsky, Ulrike, Rieunier, Guillaume, Macaulay, Valentine M.

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Regulation of proliferation and invasion by the IGF signalling pathway in Epstein‐Barr virus‐positive gastric cancer מאת Jeong, Inhye, Kang, Sun Kyoung, Kwon, Woo Sun, Kim, Hyun Jeong, Kim, Kyoo Hyun, Kim, Hyun Myong, Lee, Andre, Lee, Suk Kyeong, Bogenrieder, Thomas, Chung, Hyun Cheol, Rha, Sun Young

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors מאת Park, Keunchil, Tan, Daniel Shao Weng, Su, Wu-Chou, Cho, Byoung Chul, Kim, Sang-We, Lee, Ki Hyeong, Wang, Chin-Chou, Seto, Takashi, Huang, Dennis Chin-Lun, Jung, Helen Hayoun, Hsu, Ming-Chi, Bogenrieder, Thomas, Lin, Chia-Chi

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors מאת Ireland, Lucy, Santos, Almudena, Ahmed, Muhammad S., Rainer, Carolyn, Nielsen, Sebastian R., Quaranta, Valeria, Weyer-Czernilofsky, Ulrike, Engle, Danielle D., Perez-Mancera, Pedro A., Coupland, Sarah E., Taktak, Azzam, Bogenrieder, Thomas, Tuveson, David A., Campbell, Fiona, Schmid, Michael C., Mielgo, Ainhoa

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Nuclear IGF-1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage מאת Aleksic, Tamara, Gray, Nicki, Wu, Xiaoning, Rieunier, Guillaume, Osher, Eliot, Mills, Jack, Verrill, Clare, Bryant, Richard J., Han, Cheng, Hutchinson, Kathryn, Lambert, Adam G., Kumar, Rajeev, Hamdy, Freddie C., Weyer-Czernilofsky, Ulrike, Sanderson, Michael P., Bogenrieder, Thomas, Taylor, Stephen, Macaulay, Valentine M.

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic bre... מאת Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J. Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours מאת de Bono, Johann, Lin, Chia-Chi, Chen, Li-Tzong, Corral, Jesus, Michalarea, Vasiliki, Rihawi, Karim, Ong, Michael, Lee, Jih-Hsiang, Hsu, Chih-Hung, Yang, James Chih-Hsin, Shiah, Her-Shyong, Yen, Chia-Jui, Anthoney, Alan, Jove, Maria, Buschke, Susanne, Fuertig, René, Schmid, Ulrike, Goeldner, Rainer-Georg, Strelkowa, Natalja, Huang, Dennis Chin-Lun, Bogenrieder, Thomas, Twelves, Chris, Cheng, Ann-Lii

קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא